Author

Petrie Flom

  • Bioethics

    New from Bioethicist Art Caplan: How State Right-To-Try Laws Create False Expectations

    By Arthur Caplan A new piece by David Farber, Preeya Noronha Pinto, Bill of Health contributor Arthur Caplan, and Alison Bateman-House the Health Affairs blog: Over the past year, state Right-to-Try (RTT) laws that claim to enable terminally ill patients…

    New from Bioethicist Art Caplan: How State Right-To-Try Laws Create False Expectations

  • Health Law Policy

    Bioethicist Art Caplan: Deep-Fat Fryers in Schools is Business, Not Freedom

    By Arthur Caplan A new piece by contributor Art Caplan on NBC News: How bad is the obesity epidemic among kids in America? Bad enough that 69 percent of young adults in Minnesota cannot serve…

    Bioethicist Art Caplan: Deep-Fat Fryers in Schools is Business, Not Freedom

  • Biotechnology

    Bioethicist Art Caplan: Actress Sofia Vergara Can’t Destroy Her Embryos

    By Arthur Caplan A new piece by contributor Art Caplan on NBC News: Nick Loeb and Sofia Vergara once were a huge item. Today, they are back in the tabloid press because of a dispute over…

    Bioethicist Art Caplan: Actress Sofia Vergara Can’t Destroy Her Embryos

  • PORTAL Round-Up

    New BoH Feature: Monthly Round-Up of What to Read on Pharma Law and Policy

    By Ameet Sarpatwari and Aaron S. Kesselheim Each month, the Program On Regulation, Therapeutics, And Law (PORTAL) in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital/Harvard Medical School reviews the peer-reviewed medical literature…

    New BoH Feature: Monthly Round-Up of What to Read on Pharma Law and Policy

  • Human Rights

    What Should Customers Do About Dirty Practices of Big Companies?

    By Cansu Canca The video “Who Pays the Price? The Human Cost of Electronics” recently went viral on social media. It purports to document the suffering of former workers of Chinese electronics factories that supply smartphones…

    What Should Customers Do About Dirty Practices of Big Companies?

  • Generic Drugs

    Big relief for Big Pharma: Indian Patent Office rejects application for compulsory license

    By Aditya Gupta By a detailed order passed last week, the Indian Patent Office rejected an application for compulsory license filed by a generic drug manufacturer BDR Pharmaceuticals International Pvt. Ltd. (“BDR”) seeking a license of Bristol…

    Big relief for Big Pharma: Indian Patent Office rejects application for compulsory license

  • Health Care Reform

    Is Turkey’s Health Systems Reform as Successful as It Sounds?

    By Cansu Canca In July, the Lancet covered Turkey’s development and implementation of universal health coverage extensively in an article and in supplementary comments. The main article, written by those who are directly involved in the development…

    Is Turkey’s Health Systems Reform as Successful as It Sounds?

  • Bioethics

    What Is (Not) Wrong With Doping – Part II

    By Cansu Canca [In Part I, I considered, and rejected, arguments that doping harms the athletes and treats human nature wrongly.] Spirit of sport Let us now turn to the third objection: the use of…

    What Is (Not) Wrong With Doping – Part II